 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              Ranbaxy Laboratories Ltd has notified the Bank of New York Mellon (hereinafter "The Bank") to terminate the Deposit Agreements dated July 7, 1994 (under which the Rule 144A Global Depositary Shares / Regulation S Global Depositary Shares have been issued) and underlying GDR programme. The Bank has on October 15, 2014 issued the notice of termination of GDR Programme to the GDR holders and accordingly the Bank will complete the process of termination of GDR programme as per the terms of such notice of termination.
Shares of RANBAXY LABORATORIES LTD. was last trading in BSE at Rs.589.85 as compared to the previous close of Rs. 598.05. The total number of shares traded during the day was 96754 in over 3648 trades.
The stock hit an intraday high of Rs. 605.8 and intraday low of 586.6. The net turnover during the day was Rs. 57855935.